Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-25

Clinical Trial Update: Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating cyclosporine for dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Sirion Therapeutics, Inc. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED